[Clinical and prognostic profile evolution of patients discharged from hospital due to heart failure in the first two decades of the 21st century. The INCA-Ex Registry]. [PDF]
Fernández-Bergés D +9 more
europepmc +1 more source
[The family doctor and the barriers to prescribing the new oral anticoagulants: Heterogeneity, inequality and confusion. Statement of the Spanish Primary Care and Family Medicine Societies]. [PDF]
Lobos Bejarano JM +2 more
europepmc +1 more source
Mantenimiento de tratamientos crónicos en pacientes afectados de COVID-19. [PDF]
Sánchez JMR +2 more
europepmc +1 more source
Rol de los nuevos anticoagulantes orales en la trombosis asociada a cáncer.
Introducción: La trombosis asociada a cáncer constituye la segunda causa de mortalidad en pacientes con cáncer, con una incidencia muy superior a la de la población general.
Simón Paracuellos, Teresa +1 more
core
[Pharmacological interactions in patients treated with oral anticoagulants in a rural health area]. [PDF]
Sánchez-Garrido Escudero R +4 more
europepmc +1 more source
[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations]. [PDF]
Pallarés-Carratalá V +6 more
europepmc +1 more source
[Quality of life of patients treated with oral anticoagulants]. [PDF]
Yanes Baonza M +3 more
europepmc +1 more source
[Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain]. [PDF]
González V +5 more
europepmc +1 more source
Recomendaciones para el control del anticoagulante oral
En general la dosis del anticoagulante oral es individual y muy variable, por lo que se requiere de paciencia y tiempo para lograr una buena respuesta con el tratamiento.
openaire +1 more source

